Inventiva (IVA) News Today $6.53 +0.23 (+3.65%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$6.59 +0.06 (+0.92%) As of 10/3/2025 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IVA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Inventiva (NASDAQ:IVA) Hits New 12-Month High - What's Next?October 3 at 9:43 PM | marketbeat.comInventiva (NASDAQ:IVA) Shares Gap Up - Should You Buy?October 2 at 12:25 PM | marketbeat.comInventiva management to meet with Piper SandlerOctober 2 at 2:49 AM | msn.comCanaccord Genuity Maintains Inventiva S.A. - Depositary Receipt (IVA) Buy RecommendationOctober 1, 2025 | msn.comInventiva Appoints Andrew Obenshain as CEO to Drive U.S. Market ExpansionOctober 1, 2025 | msn.comInventiva Appoints Andrew Obenshain as Chief Executive OfficerOctober 1, 2025 | globenewswire.comInventiva (NASDAQ:IVA) Given Buy Rating at Canaccord Genuity GroupOctober 1, 2025 | americanbankingnews.comInventiva (NASDAQ:IVA) Shares Gap Down - Time to Sell?September 30, 2025 | marketbeat.comInventiva's (IVA) "Buy" Rating Reiterated at Canaccord Genuity GroupSeptember 30, 2025 | marketbeat.comInventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market SessionSeptember 29, 2025 | benzinga.comInventiva (NASDAQ:IVA) Sees Unusually-High Trading Volume - Here's What HappenedSeptember 29, 2025 | marketbeat.comInventiva reports its unaudited 2025 first-half financial results and provides a corporate updateSeptember 29, 2025 | globenewswire.comTop Wall Street Forecasters Revamp Inventiva Expectations Ahead Of H1 EarningsSeptember 29, 2025 | benzinga.comIVA Inventiva S.A.September 26, 2025 | seekingalpha.comPreview: Inventiva's EarningsSeptember 26, 2025 | benzinga.comInsights into Inventiva's Upcoming EarningsSeptember 25, 2025 | benzinga.comInventiva (NASDAQ:IVA) Shares Gap Up - Here's What HappenedSeptember 25, 2025 | marketbeat.comInventiva to Host Analyst and Investor Event on October 8, 2025September 24, 2025 | globenewswire.comInventiva (NASDAQ:IVA) Sees Large Volume Increase - Here's What HappenedSeptember 22, 2025 | marketbeat.comInventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesSeptember 21, 2025 | marketbeat.comInventiva positioned as next acquisition target, says H.C. WainwrightSeptember 18, 2025 | msn.comInventiva (IVA) to Release Quarterly Earnings on ThursdaySeptember 18, 2025 | marketbeat.comInventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest UpdateSeptember 16, 2025 | marketbeat.comInventiva (NASDAQ:IVA) Shares Gap Down - What's Next?September 14, 2025 | marketbeat.comInventiva (NASDAQ:IVA) Shares Gap Up - Time to Buy?September 12, 2025 | marketbeat.comAnalysts Offer Predictions for Inventiva FY2025 EarningsSeptember 7, 2025 | marketbeat.comInventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Up 188.0% in AugustSeptember 6, 2025 | marketbeat.comInventiva (NASDAQ:IVA) Shares Gap Up Following Analyst UpgradeSeptember 5, 2025 | marketbeat.comInventiva (NASDAQ:IVA) Receives Buy Rating from HC WainwrightSeptember 5, 2025 | marketbeat.comInventiva to Participate in Upcoming September Investor ConferencesSeptember 4, 2025 | globenewswire.comInventiva (NASDAQ:IVA) Sees Unusually-High Trading Volume After Analyst UpgradeSeptember 4, 2025 | marketbeat.comInventiva (NASDAQ:IVA) Given New $13.00 Price Target at GuggenheimSeptember 4, 2025 | marketbeat.comInventiva assumed with a Buy at H.C. WainwrightSeptember 4, 2025 | msn.comInventiva (NASDAQ:IVA) Stock Rating Upgraded by Piper SandlerAugust 31, 2025 | marketbeat.comInventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesAugust 29, 2025 | marketbeat.comInventiva (NASDAQ:IVA) Trading 4.3% Higher - What's Next?August 28, 2025 | marketbeat.comInventiva initiated with an Overweight at Piper SandlerAugust 27, 2025 | msn.comInventiva surges as Piper Sandler issues bullish view citing lead assetAugust 27, 2025 | msn.comShort Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Drops By 72.9%August 17, 2025 | marketbeat.comInventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth ConferenceAugust 12, 2025 | finance.yahoo.comHalf-Year Review of Inventiva’s Liquidity Contract with Kepler ...August 2, 2025 | morningstar.comMInventiva Announces Preliminary First-Half 2025 Financial ResultsJuly 31, 2025 | theglobeandmail.comHalf-Year Review of Inventiva's Liquidity Contract with Kepler CheuvreuxJuly 31, 2025 | globenewswire.comINVENTIVA: Inventiva Reports Preliminary 2025 First-Half Financial InformationJuly 30, 2025 | finanznachrichten.deInventiva Reports Preliminary 2025 First-Half Financial Information¹July 30, 2025 | finance.yahoo.comInventiva appoints new R&D president and regulatory affairs executiveJuly 11, 2025 | investing.comInventiva names Jason Campagna as President of R&D and Chief Medical ...July 11, 2025 | finance.yahoo.comInventiva Strengthens Leadership Team Ahead of Key MASH Drug MilestonesJuly 10, 2025 | yahoo.comInventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality AssuranceJuly 9, 2025 | globenewswire.comINVENTIVA: Inventiva receives $10 million milestone payment from CTTQJuly 8, 2025 | finanznachrichten.de Get Inventiva News Delivered to You Automatically Sign up to receive the latest news and ratings for IVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IVA Media Mentions By Week IVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IVA News Sentiment▼0.210.54▲Average Medical News Sentiment IVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IVA Articles This Week▼143▲IVA Articles Average Week Get the Latest News and Ratings for IVA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Inventiva and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CDTX News Today IRON News Today AGIO News Today TVTX News Today BLTE News Today OCUL News Today ETNB News Today ARQT News Today RXRX News Today DNLI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IVA) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inventiva S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Inventiva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IVA Stock Alerts